Who We Are
Fosmo Med is pioneering Forward Osmosis (FO) technology that allows IV solutions to be made using any kind of fresh water, clean or dirty, at the point of care.
Shipping IV bags without water provides the following advantages:
- Reduces shipping and other logical costs
- Increases product shelf life
- Reduces storage costs
- Reduces the risk of scrap due to leakage
The initial target for Fosmo Med products are disaster relief organizations such as the Red Cross, governments and military around the world.
Fosmo Med will partner with existing manufacturers and distributors to serve the current market.
Fosmo Med was founded to save the lives of millions of people who are not receiving treatment because they don’t have access to the most basic of medical supplies: an IV bag while provide a great return to our investors.
IV solutions have not changed since the 1970s, when bottles were replaced with plastic bags. Although a step in the right direction, current IV bags are still 90% water. They’re expensive to ship, have a short shelf life, and are prone to leakage.
Fosmo Med thinks it has a better solution. We are revolutionizing the logistics of IV bags by shipping them without water. Once onsite, our Forward Osmosis technology converts dirty water to clean and sterile water to create a complete IV solution.
Board of Advisors
Linda McAllister, MD PhD, is currently the Chief Medical Officer for CellScape. Previously she was the Chief Medical Officer for PharmaJet, a medical device company developing needle-free jet injection that has closed a pivotal clinical trial of influenza vaccine delivery. She was also Executive VP of Diagnostics and Chief Medical Officer of Arbor Vita Corporation. Dr. McAllister has experience in research, product development, clinical development, and business development in the biomedical field, working for companies such as Roche Diagnostics, Celera Corporation and Affymetrix.
She has been a clinical faculty member at University of California, San Francisco for 10 years and has done a post-doctoral fellowship with Drs Pat Brown and David Botstein at Stanford University School of Medicine. She finished her residency at UCSF School of Medicine. She holds MD and PhD degrees from Stanford University and a Bachelors degree from California Institute of Technology.
Fosmo Med’s motivation is simple: We want to save lives through technology.
This year around 2.2-million children will die of dehydration caused by diarrhoea. Many of these children could be saved simply by having access to an IV. But, due to the high logistical costs of shipping a saline IV bag to remote parts of the world, often these people do not receive treatment and die.
Dr. Dhiman Barua has seen this first-hand. He started working for the World Health Organization in 1965 and has trained health workers in many countries in oral rehydration therapy and other aspects of diarrhoeal diseases. Dr. Barua describes his first experience with cholera in this excerpt from an interview in the Bulletin of the World Health Organization:
“My first memory of cholera was when I was 11. The village in what is today Bangladesh was dying of cholera. I asked the doctor why and he told me that the only treatment was intravenous saline (IV) and that, without it, people die. And before my eyes, the doctor, his wife – who was related to me – and their two daughters died. Our household was not affected, but most households in the village were affected. People died like flies. That was really shocking.”
At Fosmo Med, we believe we can help save lives by providing our IV bag solution to NGOs around the world. Our solution will significantly lower shipping costs, provide safer storage, and improve transport to hard-to-reach regions throughout the world. This could eventually save hundreds of thousands of lives annually.
Here are what some leading influencers are saying about Fosmo Med:
“After bringing hundreds of physicians in dozens of trips to disaster areas — including New Orleans after Katrina, Haiti and Japan — my sore back can attest to the difficulty of physically bringing IV fluids into disaster zones. Airlines allow only 50 pounds per checked-in luggage, which can carry only a few IV bags. If I instead had the ability to bring dry IV bags that could be filled up at the location of the disaster, I could help save many, many more lives. This need is made even more acute by recent outbreaks of diseases that cause severe dehydration, such as cholera, which we have been treating in Haiti. Cholera in Haiti is quite simple to treat — you can save lives if you can rehydrate victims and give them almost any antibiotic. Their lives are mostly saved by the rehydration, and often survive even if they cannot receive any antibiotic.
Please help save lives by helping Fosmo Med bring its IV hydration product to market.”
Enoch Choi, MD, Medical Director, Jordan International Aid, a 501c3 disaster relief organization
“Fosmo Med is creating a revolutionary solution to a costly care-delivery issue. The Fosmo Med System has a unique and unprecedented potential to meaningfully alter the way patients are cared for nationally and internationally, during both routine and emergent care. The intuitive and cost-altering approach is overdue in its readiness for use by clinicians in the care of patients.”
Diane M. Cooper, PhD, Fellow of the American Academy of Nursing
“As a Director of Spend Management for Cardinal Health’s “M” segment and someone from inside the healthcare industry for more than 25 years — including Boston Scientific, Pharma and Oncology Distribution — I am extremely confident the Fosmo Med product line is staged (pending FDA approvals) to overtake and change the world of healthcare IV solution technology. All medical surgical manufacturers and distributors of healthcare IV and irrigating solutions will be overwhelmed with the stellar performance of Fosmo Med product lines.”
Phillip E. Pellerin, MD Foundry, Senior Advisor Board member – Medical Device Technologies
© 2015 Fosmo Med